Novavax COVID-19 Vaccine Approved for Use in Japan

Novavax COVID-19 Vaccine Approved for Use in Japan
A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, on Oct. 30, 2020. Dado Ruvic/Reuters
|Updated:

Japan’s Health Ministry on Monday approved the use of Novavax’s protein-based COVID-19 vaccine, making it the fourth vaccine option available for people aged 18 and above.

Japan has contracted to buy 150 million doses of the vaccine, which will be manufactured domestically by Takeda Pharmaceutical Co. Takeda first applied for approval in December last year, local media Kyodo News reported.
Aldgra Fredly
Aldgra Fredly
Author
Aldgra Fredly is a freelance writer covering U.S. and Asia Pacific news for The Epoch Times.
Related Topics